Impact of metformin versus repaglinide on postprandial glycaemia and plasma lipoproteins in non-obese patients with type-2 diabetes mellitus (T2DM)

被引：0
|
作者：
Lund, S. S. [1 ]
Tarnow, L. [1 ]
Smidt, U. M. [1 ]
Frandsen, M. [1 ]
Pedersen, O. [1 ]
Parving, H-H. [1 ]
Vaag, A. A. [1 ]
机构：
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71734-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] Effects on lipid metabolism of metformin and troglitazone, alone and in combination, in patients with type 2 diabetes mellitus (T2DM)
    Lee, I
    Maggs, DG
    Katz, D
    Spollett, GR
    Page, SL
    Rife, FS
    Inzucchi, SE
    DIABETES, 2002, 51 : A105 - A105
  • [32] Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus
    Wang, Yanjun
    Wu, You
    Yang, Shuangzhu
    Chen, Yan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 629 - 642
  • [33] EXAMINING RISK FOR COMORBID MDD AND TYPE 2 DIABETES MELLITUS (T2DM) IN OBESE YOUTH: THE IMPACT TRIAL
    Hardin, Heather K.
    Mcvoy, Molly
    Gubitosi-Klug, Rose
    Borawski, Elaine
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S159 - S159
  • [34] PHARMACOTHERAPY OPTIMIZATION PLAN FOR PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM) AND HYPERTENSION IN A CHILEAN HEALTHCARE SETTING: IMPACT AND OUTCOMES
    Soto, A.
    Avila, X.
    Cordova, P.
    Fernandez, P.
    Lopez, M.
    Villa, L. A.
    Morales, F.
    VALUE IN HEALTH, 2015, 18 (03) : A260 - A260
  • [35] Early-stage deficiencies in insulin signaling in an animal model of non-obese type 2 diabetes (T2DM)
    Whitehead, Timothy
    Schweitzer, George
    Rani, Sudheer
    Devanathan, Sriram
    Fettig, Nicole
    Nemanich, Samuel
    Finck, Brian
    Shoghi, Kooresh
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [36] Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
    Lund, S. S.
    Tarnow, L.
    Stehouwer, C. D. A.
    Schalkwijk, C. G.
    Frandsen, M.
    Smidt, U. M.
    Pedersen, O.
    Parving, H. -H.
    Vaag, A.
    DIABETES OBESITY & METABOLISM, 2007, 9 (03): : 394 - 407
  • [37] LEVELS OF PLASMA SOLUBLE PRORENIN RECEPTOR (SPPR) IN OBESE PATIENTS ARE ASSOCIATED WITH TYPE 2 DIABETES MELLITUS (T2DM) IN WOMEN BUT NOT IN MEN
    Feroz, M. A.
    Rosales, C. B.
    Arita, D.
    Thethi, T.
    Fonseca, V.
    Prieto, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 696 - 696
  • [38] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [39] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [40] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
12345